MRKR CIK: 1094038

Marker Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−39.5
FY22:
−19.8
FY23:
−14.6
FY24:
−11.1
FY25:
−12.9
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−19.8
FY23:
−14.0
FY24:
−10.7
FY25:
−12.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−41.9
FY22:
−29.9
FY23:
−8.24
FY24:
−10.7
FY25:
−12.2

All amounts in millions USD Data source:SEC EDGAR